S 
1,074
+2.38%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in JPY, from our data supplier.
Revenue
¥6.84bn
FY2019FY2025
Net income
¥187.6m
FY2019FY2025
Free cash flow
¥147.8m
FY2019FY2025
Shareholders' equity
¥2.93bn
FY2019FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | ¥6.84bn | ¥6.25bn | ¥5.19bn | ¥3.38bn | ¥3.38bn | ¥2.79bn | ¥1.72bn |
| Gross profit | ¥2.83bn | ¥2.46bn | ¥1.97bn | ¥1.27bn | ¥1.28bn | ¥1.07bn | ¥777.8m |
| Research and development | — | ¥14.9m | ¥38.7m | ¥80.6m | ¥21.0m | ¥54.6m | ¥66.2m |
| Operating income | ¥322.5m | ¥305.7m | ¥188.0m | −¥191.5m | ¥155.4m | ¥35.6m | −¥49.5m |
| Net income | ¥187.6m | ¥240.6m | ¥168.8m | −¥227.6m | ¥131.5m | ¥33.0m | −¥47.2m |
| Diluted earnings per share | 33.87 | 48.56 | 33.30 | -48.30 | 28.64 | 5.32 | -7.60 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Total assets | ¥5.26bn | ¥3.79bn | ¥2.75bn | ¥1.99bn | ¥1.98bn | ¥1.47bn | ¥1.26bn |
| Cash and short-term investments | ¥2.25bn | ¥1.20bn | ¥809.0m | ¥474.2m | ¥675.9m | ¥372.1m | ¥496.3m |
| Total liabilities | ¥2.33bn | ¥2.51bn | ¥1.73bn | ¥1.15bn | ¥1.00bn | ¥1.01bn | ¥839.3m |
| Debt | ¥1.04bn | ¥1.43bn | ¥880.2m | ¥617.7m | ¥500.7m | ¥641.0m | ¥545.7m |
| Shareholders' equity | ¥2.93bn | ¥1.28bn | ¥1.02bn | ¥842.1m | ¥983.1m | ¥455.2m | ¥421.7m |
| Shares outstanding | 6m | 5m | 5m | 5m | 5m | 6m | 6m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Cash from operations | ¥220.0m | ¥331.3m | ¥99.2m | −¥268.3m | ¥122.2m | −¥132.1m | −¥145.3m |
| Capital spending | −¥72.2m | −¥37.9m | −¥21.5m | −¥83.1m | −¥9.8m | −¥26.1m | −¥12.3m |
| Free cash flow | ¥147.8m | ¥293.4m | ¥77.7m | −¥351.4m | ¥112.4m | −¥158.2m | −¥157.6m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ¥1.74bn | ¥2.37bn | ¥1.89bn | ¥1.65bn | ¥1.49bn | ¥1.81bn | ¥1.52bn | ¥1.58bn |
| Gross profit | ¥703.0m | ¥960.8m | ¥792.2m | ¥702.1m | ¥599.9m | ¥733.9m | ¥615.8m | ¥606.2m |
| Operating income | −¥3.4m | ¥234.9m | ¥121.2m | ¥89.1m | −¥36.7m | ¥152.5m | ¥16.1m | ¥51.4m |
| Net income | −¥61.7m | ¥151.0m | ¥83.4m | ¥54.6m | −¥46.5m | ¥96.1m | ¥26.9m | ¥28.0m |
| Diluted earnings per share | -9.94 | 24.32 | 15.06 | 9.86 | -8.40 | 17.36 | 5.42 | 5.65 |
| Total assets | ¥8.00bn | ¥6.93bn | ¥5.26bn | ¥5.04bn | ¥5.00bn | ¥5.50bn | ¥3.79bn | ¥3.90bn |
| Cash and short-term investments | ¥3.22bn | ¥3.12bn | ¥2.25bn | ¥2.32bn | ¥2.38bn | ¥2.55bn | ¥1.20bn | ¥1.39bn |
| Debt | ¥1.85bn | ¥844.3m | ¥1.04bn | ¥464.4m | ¥1.15bn | ¥679.5m | ¥592.5m | ¥597.0m |
| Shareholders' equity | ¥3.99bn | ¥4.02bn | ¥2.93bn | ¥2.85bn | ¥2.79bn | ¥2.83bn | ¥1.28bn | ¥1.25bn |
Financial ratios
Data as of 5 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Gross margin | 41.3% | 39.3% | 38.0% | 37.6% | 38.0% | 38.4% | — |
| Operating margin | 4.7% | 4.9% | 3.6% | -5.7% | 4.6% | 1.3% | — |
| Net margin | 2.7% | 3.9% | 3.3% | -6.7% | 3.9% | 1.2% | — |
| Return on equity | 6.4% | 18.8% | 16.5% | -27.0% | 13.4% | 7.3% | — |
| Return on assets | 3.6% | 6.3% | 6.1% | -11.4% | 6.6% | 2.2% | — |
| Free cash flow yield | 2.9% | 4.9% | 1.4% | -4.2% | 2.0% | — | — |
| Revenue growth | 9.5% | 20.3% | 53.4% | 0.2% | 21.1% | 62.5% | — |
| Earnings growth | -22.0% | 42.5% | -174.2% | -273.1% | 298.0% | -170.0% | — |
| Current ratio | 2.68x | 1.91x | 2.01x | 1.97x | 2.12x | 1.74x | — |
| Debt to equity | 0.35x | 1.11x | 0.86x | 0.73x | 0.49x | 1.36x | — |
| Equity ratio | 55.7% | 33.8% | 37.2% | 42.2% | 49.5% | 31.0% | — |
| Interest coverage | 22.92x | 24.06x | 25.08x | -33.95x | 22.31x | 5.03x | — |
| R&D as a share of sales | — | 0.2% | 0.7% | 2.4% | 0.6% | 2.0% | 3.9% |
| Buybacks as a share of market value | -11.8% | 2.3% | -7.6% | -2.7% | — | — | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 26.4% | 19.6% | — |
| Operating income | — | 55.4% | — |
| Net income | — | 41.5% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 40.4% | 39.4% | 39.1% | — |
| Operating margin | 4.8% | 2.9% | 2.9% | — |
| Net margin | 3.3% | 1.7% | 1.9% | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Price to earnings | 42.8 | 37.3 | 46.6 | -12.5 | 82.6 |
| Price to sales | 1.2 | 1.4 | 1.5 | 0.8 | 3.2 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.